Development of a Human Endometrium-on-a-Chip to Model Human Embryo Adhesion

Synopsis

Embryo implantation is a crucial step for the establishment of pregnancy and consists of three sequential stages: apposition, adhesion to the endometrium, and invasion into the decidua. Among these, embryo adhesion is a highly coordinated process that remains poorly understood due to the lack of physiologically relevant human in vitro models capable of capturing these early events. To address this challenge, researchers from the Carlos Simon Foundation have developed a human Endometrium-on-a-Chip using Emulate’s Organ-on-a-Chip technology to recreate the dynamic endometrial microenvironment.

The Endometrium-on-a-Chip was established by combining organoid-derived endometrial epithelial cells in the upper channel with primary endometrial stromal cells in the lower channel. The model was optimized to generate a stable and hormonally responsive endometrial tissue and characterized through the assessment of epithelial polarization, extracellular vesicle secretion, epithelial receptivity, and stromal decidualization.

Single-cell RNA sequencing was performed to define the cellular composition of the model and characterize the identity and heterogeneity of both epithelial and stromal populations. The platform was further used to investigate how pharmacological disruption of endometrial receptivity with mifepristone influences embryo attachment, with changes in receptivity-associated gene expression confirming the effect of the treatment.

The model was validated by introducing mouse embryos as a proof of concept, demonstrating its suitability for studying the initial stages of embryo implantation. Human blastocysts were then incorporated into the platform to capture and characterize the events associated with embryo adhesion, revealing trophectoderm-mediated attachment, embryo reorganization, and trophoblast functionality and differentiation.

Together, these findings establish the Endometrium-on-a-Chip as a robust and physiologically relevant platform for investigating early embryo implantation and endometrial receptivity. The versatility of the model also provides a foundation for future applications, including modeling endometrial disorders and evaluating pharmacological modulation in a human-relevant in vitro system.

Emulate Community Publications Digest: Fall 2026 Issue

With over 150 peer-reviewed publications across 35+ organ models, Emulate Organ-Chips are empowering researchers to make game-changing scientific breakthroughs! Download this digest to easily explore all publications related to your field of research, or to just learn more about how the technology itself is developing.

New this quarter:

Endometrium

  • Modeling human embryo adhesion using a microfluidic platform

Blood-Brain Barrier

  • A human 3D BBB chip model of acute stroke simulating a reversible penumbra

PROTOCOL:

Lung (Tumor)

  • Protocol for generation of a 3D humanized lung-tumor-on-a-chip model of immune-hot and immune-cold microenvironments

PRE-PRINT:

Intestine (Ileum)

  • Discovery of a radiation countermeasure therapeutic for intestinal injury enabled by human organ chips combined with AI

Modeling human embryo adhesion using a microfluidic platform

Organ Model: Endometrium

Application: Reproductive Biology

The authors created an endometrium-on-a-chip model containing organoid-derived endometrial epithelial cells in one channel and primary stromal cells in the other. The model reproduced key features of endometrial physiology, including epithelial polarization, stromal decidualization, hormone-induced receptivity, extracellular vesicle secretion, and signaling between the epithelial and stromal compartments. After hormonal treatment, the Organ-Chip supported adhesion of both mouse and human blastocysts, enabling live observation of embryo attachment, trophectoderm spreading, inner cell mass repositioning, and early lineage reorganization. The platform also responded to the contraceptive mifepristone, demonstrating its potential for studying implantation disorders and screening compounds that influence embryo–endometrium interactions.

Products Used In This Publication

Human organ-on-a-chip technology as a catalyst for drug discovery (Review)

Application: Drug Discovery

This review highlights Organ-Chips as a more human-relevant preclinical platform that recreates key aspects of organ physiology—including tissue-tissue interfaces, dynamic fluid flow, mechanical forces, and immune interactions—to improve prediction of human drug responses. Unlike conventional cell cultures or animal models, Organ-Chips enable therapeutics to be evaluated using clinically relevant dosing routes and pharmacokinetic profiles, supporting more accurate assessment of efficacy, toxicity, and mechanisms of resistance. The authors also emphasize that combining Organ-Chips with high-throughput screening, functional genomics, and artificial intelligence could accelerate target identification and drug discovery while helping reduce the high rate of clinical trial failures. Although challenges remain around standardization and scalability, the review concludes that Organ-Chips are poised to become an increasingly important tool for drug development and regulatory safety assessment.

Enabling Drug Development with NAMs: Scalable Imaging and AI Analysis Workflows for Organ-Chips

Synopsis

Organ-on-a-Chip technology is emerging as a powerful New Approach Methodology (NAM) for drug development, driven by the need for more human-relevant and scalable experimental models. As these systems move toward broader adoption, a key challenge remains: generating consistent, interpretable data that supports confident experimental and translational decision-making.

This webinar examines how imaging and AI-driven analysis workflows enable Organ-Chip studies to scale from innovation to routine application. Speakers begin with an overview of Organ-on-a-Chip technology and its role in addressing translational gaps in drug discovery, highlighting how Liver-Chips are being evaluated in collaboration with regulatory agencies for better prediction of drug-induced liver injury.

The session then explores how the newly released AVA™ Emulation System enables scalable Organ-Chip experimentation through an integrated system for incubation, microfluidic delivery, and routine imaging. Paired with AI-driven analysis, brightfield image data can be used to automate quality control by monitoring chip health, morphology, and assay performance over time across large studies.

To complete the workflow, post-study high-resolution imaging is applied to evaluate more complex biological markers, including toxicology-relevant endpoints and drug uptake. These datasets are paired with advanced analysis techniques that translate imaging data into quantitative, biologically meaningful insights.

Attendees will gain a practical understanding of how unified imaging and analysis strategies—spanning routine QC through advanced interrogation—support scalability, reproducibility, and alignment with evolving regulatory expectations for Organ-Chips and other NAM-based drug development.

Female Reproductive Tract Organ-on-Chips: Modeling Barrier Function and Drug Transport (Review)

Organ Model: Female Reproductive Tract (Vagina, Cervix, Endometrium, Placenta)

Application: Infectious disease, immunology & inflammation, and maternal–fetal interface dynamics

This review examines how Organ-on-a-Chip models of the vagina, cervix, endometrium, and placenta can recreate the distinct biological barriers of the female reproductive tract more accurately than conventional cell cultures or animal models. It highlights applications including studies of host–microbiome interactions, hormonal responses, infection, placental transfer, and the transport and safety of drugs, nanoparticles, and biologics. The authors note that placenta-on-chip systems currently offer the most advanced quantitative drug-transport capabilities, while lower reproductive tract models still require greater standardization and validation. Future progress will depend on incorporating immune cells, vascular networks, patient-derived tissues, and interconnected multi-organ systems to improve preclinical drug testing and support personalized approaches in women’s health.

Products Used In This Publication

Simvastatin Restores Uteroplacental Hemodynamics and Trophoblast Function in Obstetric Antiphospholipid Syndrome in a Placenta-on-a-Chip Model

Organ Model: Placenta

Application: Reproductive Biology, Immunology & Inflammation

In this study, researchers created a Placenta-on-a-Chip to recreate the maternal–fetal interface and model trophoblast invasion into maternal endothelial tissue under physiologically relevant fluid flow and shear stress. The Placenta-Chip enabled the team to investigate how elevated shear stress, which mimics the abnormal hemodynamics observed in obstetric antiphospholipid syndrome (OAPS), impairs trophoblast invasion and spiral artery remodeling. Using the model, they demonstrated that simvastatin restored trophoblast invasion under high-shear conditions by improving endothelial function, reducing inflammation, and activating the KLF2/eNOS signaling pathway. These findings highlight the value of Organ-Chips for studying placental vascular biology and evaluating potential therapies for pregnancy complications driven by abnormal maternal–fetal hemodynamics.

Products Used In This Publication

Human fallopian tube-on-a-chip for preclinical testing of non-hormonal contraceptives with living human sperm

Organ Model: Fallopian Tube

Application: Reproductive Biology

In this study, researchers developed a human Fallopian Tube-on-a-Chip (FT Chip) using primary human fallopian tube epithelial cells and stromal fibroblasts to recreate the structure and function of the fallopian tube under physiologically relevant conditions. The FT Chip generated hormone-responsive epithelial folds that more closely resembled native tissue than conventional organoid cultures and enabled the study of interactions between living human sperm and the fallopian tube microenvironment. By tracking sperm behavior under fluid flow and comparing it with oocyte-sized particles, the model demonstrated the fallopian tube’s role as a sperm reservoir and provided a functional platform for reproductive biology studies. The researchers further used the FT Chip to evaluate the non-hormonal contraceptive TDI-11861, showing dose-dependent inhibition of human sperm motility and highlighting the model’s potential as a preclinical platform for contraceptive testing.

Products Used In This Publication

Human Cervix Chip: A Preclinical Model for Studying the Role of the Cervical Mucosa and Microbiome in Female Reproductive Health

Organ Model: Cervix

Application: Reproductive Biology, Microbiome

In this review, the authors highlight how the human Cervix-Chip replicates essential cervical functions such as mucus production and responses to hormonal, microbial, and environmental cues. They describe its value as a preclinical model for studying mucosal immunity, microbiome interactions, and risk factors in reproductive health and disease. The chip is presented as a translational platform to advance drug screening, diagnostics, and therapeutic development for women’s health.

Products Used In This Publication

Induction of cervical dysfunction associated with preterm birth by IL-1 and dysbiotic microbiome revealed in human endocervix chips

Organ Model: Cervix

Application: Reproductive Biology, Microbiome

The authors created a human Endocervix-Chip lined with primary epithelial and stromal cells under pregnancy-like hormonal conditions, which reproduced cervical functions such as mucus plug formation with antimicrobial properties. By introducing dysbiotic microbiota, inflammatory cytokines, and immune cells, they modeled pathological processes linked to preterm labor, including inflammation, extracellular matrix degradation, and cervical ripening. The chip was further used to evaluate therapeutics, confirming the ineffectiveness of a discontinued drug while showing that IL-1 receptor blockade prevented cervical dysfunction.

Products Used In This Publication